In contrast, in a study of a Bulgarian patient sample population, IL-18 levels were found to be within the normal range or even reduced, which could indicate some ambiguity in the interpretation of the role played by IL-18 in MS [35,38,42]. Here, IL18 is linked to myeloid sarcoma.